Overview: Triglycerides TestIntroduction: The Triglycerides Test measures triglycerides to diagnose heart disease risk, causing chest pain. Following 2023 ACC guidelines, it uses biochemical methods for high specificity, supporting metabolic screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with cardiovascular risk.
Other Names: Triglyceride Assay, Lipid Profile Component Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Triglyceride testing began in the 1960s with lipid research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures triglycerides to diagnose heart disease risk, guides treatment, and evaluates patients with chest pain.
Test Parameters: 1. Triglyceride Level
Pretest Condition: Fasting for 10-12 hours required. Collect serum or plasma. Report history of chest pain or cardiovascular symptoms.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document chest pain, family history of heart disease, or lipid disorders. Include current medications, especially statins.
Consent: Written consent required, detailing the tests purpose, heart disease implications, and risks of sample collection.
Procedural Considerations: Uses enzymatic assays to measure triglyceride levels. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for cardiovascular risk assessment.
Factors Affecting Result Accuracy: Improper fasting or sample hemolysis can affect results. Medications like fibrates may alter levels.
Clinical Significance: Elevated triglycerides confirm heart disease risk, guiding lifestyle changes or lipid-lowering therapy. Normal levels may require LDL or HDL testing.
Specialist Consultation: Consult a cardiologist for result interpretation and treatment planning.
Additional Supporting Tests: Lipid panel, LDL, HDL, or cardiac stress testing to assess heart disease risk.
Test Limitations: Non-specific for heart disease cause; clinical correlation is needed. Sample quality affects sensitivity.
References: ACC Lipid Guidelines, 2023; Journal of the American College of Cardiology, Grundy SM, 2022.
